144 related articles for article (PubMed ID: 8110494)
1. Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancer.
Quoix E; Charloux A; Popin E; Pauli G
Eur J Cancer; 1993; 29A(16):2248-50. PubMed ID: 8110494
[TBL] [Abstract][Full Text] [Related]
2. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA
Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878
[TBL] [Abstract][Full Text] [Related]
3. [Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma].
Gasser RW; Herold M; Müller-Holzner E; Müller LC; Salzer GM; Huber H
Dtsch Med Wochenschr; 1988 Nov; 113(44):1708-13. PubMed ID: 2846253
[TBL] [Abstract][Full Text] [Related]
4. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
Carney DN; Marangos PJ; Ihde DC; Bunn PA; Cohen MH; Minna JD; Gazdar AF
Lancet; 1982 Mar; 1(8272):583-5. PubMed ID: 6121182
[TBL] [Abstract][Full Text] [Related]
5. [The usefulness of serum neuron-specific enolase in the clinical management of small-cell lung carcinoma].
Sánchez de Cos Escuín J; Masa Jiménez F; Disdier Vicente C; de la Cruz Ríos JL; Vergara Fiordia C; Domínguez Retortillo C; Fuentes Otero F
Arch Bronconeumol; 1994 Oct; 30(8):375-80. PubMed ID: 7987543
[TBL] [Abstract][Full Text] [Related]
6. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
7. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
[TBL] [Abstract][Full Text] [Related]
8. Concomitant monitoring of serum neuron-specific enolase and creatine kinase BB in small cell lung cancer.
Liippo KK; Terho T
Acta Oncol; 1991; 30(3):321-4. PubMed ID: 1645171
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
Jørgensen LG; Hirsch FR; Skov BG; Osterlind K; Cooper EH; Larsson LI
Br J Cancer; 1991 Jan; 63(1):151-3. PubMed ID: 1703432
[TBL] [Abstract][Full Text] [Related]
10. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
[TBL] [Abstract][Full Text] [Related]
11. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer].
Mori Y; Hoshi H; Jinnouchi S; Harada K; Onoe K; Nagamachi S; Ozawa M; Watanabe K; Tawara Y
Radioisotopes; 1987 Feb; 36(2):78-80. PubMed ID: 3033753
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
Batandier C; Brambilla E; Nagy-Mignotte H; Laporte F; Jacrot M; Beriel H; Paramelle B; Brambilla C
Scand J Clin Lab Invest; 1989 Feb; 49(1):33-42. PubMed ID: 2543057
[TBL] [Abstract][Full Text] [Related]
14. Cut-off levels of NSE to differentiate SCLC from NSCLC.
Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K
Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631
[TBL] [Abstract][Full Text] [Related]
15. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
Yang J; Li R; Li A
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
[TBL] [Abstract][Full Text] [Related]
17. 201Tl/67Ga uptake ratio in small cell carcinoma of the lung: with special reference to serum neuron-specific enolase and prognosis.
Togawa T; Higuchi Y; Kimura K
Oncology; 1987; 44(4):228-31. PubMed ID: 3039432
[TBL] [Abstract][Full Text] [Related]
18. Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma.
van de Pol M; Twijnstra A; ten Velde GP; Menheere PP
J Neurooncol; 1994; 19(2):149-54. PubMed ID: 7964990
[TBL] [Abstract][Full Text] [Related]
19. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer].
Wei T; Luo RC; Zuo Q; Zhang JY; Miao JX; Lu HF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific enolase, thymidine kinase, and tissue polypeptide-specific antigen in diagnosis and response to chemotherapy of small-cell lung cancer.
Abbasciano V; Sartori S; Trevisani L; Nielsen I; Ferrazzi E; Bononi A; Toso S; Crepaldi G; Bianchi MP; Gilli G; Zavagli G
Cancer Detect Prev; 1999; 23(4):309-15. PubMed ID: 10403902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]